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The metabolic syndrome is complicated by nephropathy in
humans and rats, and males are more affected than females.
We hypothesized that female rats had reduced expression of
glomerular oxidized low-density lipoprotein (oxLDL) receptor
1 (LOX-1), attendant glomerular oxidant injury, and renal
inflammation. Three groups, obese males (OM), obese
females (OF), and lean males (LM) of first-generation (F1)
hybrid rats derived from the Zucker fatty diabetic (ZDF) strain
and the spontaneous hypertensive heart failure rat (SHHF/
Gmi-fa) were studied from 6 to 41 weeks of age. OM had
severe renal oxidant injury and renal failure. Their glomeruli
expressed the LOX-1, and exhibited heavier accumulation of
the lipid peroxide 4-hydroxynonenal (4-HNE). OM had
compromised mitochondrial enzyme function, more renal
fibrosis, and vascular leakage. Younger LM, OM, and OF ZS
(ZDF/SHHF F1 hybrid rat) rats, studied from 6 to 16 weeks of
age, showed that unutilized renal lipids were comparable in
OM and OF, although young OM had worse nephropathy and
inflammation. In conclusion, glomerular LOX-1 expression is
coupled to deposits of 4-HNE and glomerulosclerosis in OM.
We presume that LOX-1 enhances glomerular uptake of
oxidized lipids and renal inflammation, causing greater
oxidant stress and severe glomerulosclerosis. In OF, renal
protection from lipid oxidants appears to be conferred by
blunted glomerular LOX-1 expression and renal
inflammation.
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The number of patients with end-stage renal disease and
non-insulin-dependent diabetes plus dyslipidemia and
hypertension continues to increase.1–3 Hence, known factors
for cardiovascular disease may also promote nephropathy.4,5
The linkage of renal disease with non-insulin-dependent
diabetes plus dyslipidemia4–6 is not surprising, as increased
levels of oxidized low-density lipoprotein (oxLDL) is
common in non-insulin-dependent diabetes.7,8 Indeed,
reductions of oxLDLs are beneficial to renal function.9
Dyslipidemia and non-insulin-dependent diabetes-
associated injury has been shown in kidneys of CAD/
spontaneous hypertensive heart failure (SHHF) F1 hybrid
rats by us,10 in hearts of Zucker fatty diabetic (ZDF) rats11
and in kidneys of db/db mice12 by others. ZDF rats have a
defective leptin receptor;13,14 they are hyperphagic and
obese, have insulin resistance, hyperglycemia, hyperinsu-
linemia, hypertriglyceridemia, and hypercholesterolemia.15,16
Nephropathy is common in ZDF rats, and it is linked to
lipid peroxidation.15 However, over 80% of ZDF rats (fa/fa)
also have congenital non-obstructive urinary-collecting
system dilatation, and that may limit their utility for renal
investigations.16,17 Accordingly, we studied a closely related
model: the ZDF/SHHF F1 hybrid rat (ZS rat). The parent
SHHF rat is a corpulent rat with hypertension, insulin
resistance, diabetes, and acquires glomerulosclerosis.17,18
SHHF rats are derived from spontaneously hypertensive
rats and Koletsky obese rats,19 which also harbor the ‘fatty’
mutation.20
We found that nephropathy in ZS rats is more severe in
obese male (OM) than in obese female (OF) rats while
ingesting a common laboratory rat diet rich in lipid
peroxides. Remarkably, renal lipid deposition was compar-
able in males and females and did not link to renal injury.
However, renal injury was linked to renal expression of the
oxLDL receptor 1 (LOX-1) and to renal inflammatory cell
infiltrates, which were far more prominent in males than
females.
http://www.kidney-international.org o r i g i n a l a r t i c l e
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RESULTS
Morphometric and metabolic parameters
Obese rats were morbidly obese by 41 weeks of age, with
average weights for OM and OF of 659723 and 580716 g,
respectively. In contrast, lean males (LM) weighed less than
OM: 54678 g (Po0.01; analysis of variance (ANOVA),
Table 1). Hence, severity of diabetes did not arrest growth
of ZS hybrid rats, as reported in streptozotocin-induced
diabetes.21 OM kidneys were larger than those of OF,
and kidneys in both obese groups were larger than those
of LM (Po0.05, ANOVA, Table 1). In contrast, heart
weights were slightly, but not significantly increased in OM
(not shown). In contrast, hepatomegaly was far more
severe in OM than in OF and LM (ANOVA, Po0.001),
although OF had larger livers than LM (ANOVA, Po0.001,
Table 1).
It is noteworthy that while systolic blood pressure was
significantly elevated in OM and OF when compared to LM
(Po0.01, Table 1), serum creatinine levels were only elevated
in OM (Po0.01, Table 1).
Triglyceride levels were markedly increased in OM and OF,
with final values in both obese groups over 50-fold higher
than in LM. In contrast, plasma cholesterol and glucose were
higher in OM than in the other two groups (Table 1).
Sequential measurements of plasma triglycerides in the two
obese groups confirmed that significant elevations of plasma
triglycerides occurred early, and were progressive over the
course of the experiment (Figure 1a). Cholesterol elevations
in OM were more severe than in OF, and steeply progressed
after 28 weeks of age (Figure 1b). On the other hand, glucose
levels rose relatively rapidly in OM, and declined after 28
weeks of age (Figure 1c).
Lipid peroxidation
Plasma hydroperoxide levels were measured to assess the state
of lipid peroxidation of blood components, and thus the
potential for target tissue oxidation at 41 weeks of age.10 OM
and female rats had comparable elevations of plasma
hydroperoxides: 5797139 and 6507112 mM, respectively
(Figure 2, top). Their values were markedly higher than
those of LM on the same diet: 126711 mM (ANOVA,
Po0.05). Hence, OM and female rats appeared to have
comparable risks for sustained lipid peroxidation.
Concurrent levels of plasma free aldehydes, measured
as thiobarbituric acid-reactive substances (TBARS), were
also included (Figure 2, bottom). The pool of circulating
aldehydes reflects contributions from dietary aldehydes plus
oxidized tissue and blood components, and thus it is a coarse
index of previous oxidation.22 OM had the highest levels of
TBARS, 2274 (mM), and those were significantly different
than in OF, 1271, and LM, 871 (ANOVA, Po0.01).
Renal LOX-1
The possibility that excessive lipid oxidant stress in OM
was accompanied by higher expression of the renal LOX-1
was also explored, as LOX-1 is linked to atherogenesis.23,24
The most extensive LOX-1 expression was in glomeruli of
OM (Figure 3a), with lower expression in OF (Figure 3b) and
LM (Figure 3c) (Po0.05, ANOVA). The averaged data
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Figure 1 | The evolution of the metabolic syndrome. Progressive
and severe increases in (top) triglyceride were comparable in OM and
OF. Hypercholesterolemia (middle) occurred early and was sustained
in OM. The other groups were less affected. Persistent hyperglycemia
(bottom) was common to both groups, although more severe in OM
than in OF.
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Figure 2 | Plasma hydroperoxide and TBARS levels. (a) The top
panel shows that OM and OF rats had marked but comparable
elevations of plasma hydroperoxide, and both were significantly
lower in LM. (b) The bottom panel shows that although plasma
TBARS were highest in OM, they were significantly lower in OF
and LM.
Table 1 | Rat morphometric and metabolic summary at
termination
Parameter LM OM OF
Body weight 54678 659723a 580716a,b
Kidney weight (g) 1.5670.02 3.3170.07a 1.8370.04a,b
Heart weight (g) 1.6870.06 1.8470.02 1.7370.04
Liver weight (g) 1671 4072a 2471a,b
SBP (mm Hg) 13174 16175a 17572a
Creatinine (mM) 4271 8678a 4671b
Triglycerides (mM) 271 104718a 127716a
Cholesterol (mM) 2.170.1 18.672.9a 7.671.2b
Glucose (mM) 8.070.1 19.273.8a 11.770.5b
LM, lean males; OF, obese females; OM, obese males; SBP, systolic blood pressure.
aDifferent than LM, Po0.01.
bDifferent than OM, Po0.05.
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representing the percent of glomerular areas labeled with
LOX-1 antibody (Table 2).
Renal 4-hydroxynonenal and renal pathology
We considered that the combination of high levels of
circulating lipid hydroperoxides plus increased glomerular
LOX-1 expression might promote accumulation of glomer-
ular lipid peroxides. Accordingly, we searched for renal
deposition of lipid peroxidation-derived 4-hydroxynonenal
(4-HNE) adducts with a specific rabbit polyclonal antibody
to 4-HNE adducts.10 The results were expressed as percent
glomerular area deposition of 4-HNE adducts (Table 2, and
illustrated in representative microphotographs (Figure 4).
Glomerular 4-HNE adducts were pronounced in kidneys of
obese males (Figure 4a) and much lower in either glomeruli
from OF (Figure 4b).
The higher levels of serum creatinine in OM (Table 1)
were consistent with more severe renal injury, and this
possibility was verified with renal morphometric analysis
(Table 2 and Figure 5). OM had more glomerulosclerosis,
70717 (expressed as % sclerotic glomeruli), than OF, 1371,
and LM, 171 (ANOVA, Po0.001). The percent of dilated
and atrophic tubules was higher in OM, 5074 (% of dilated
tubules), than in OF and LM, 1073 and 0.170.1 (ANOVA;
Po0.001). The percent of interstitial fibrosis was widespread
and far more extensive in OM, 9174, than in OF and LM,
3977 and 671 (ANOVA; Po0.001). Moreover, renal levels
of immunoreactive transforming growth factor b-1 (TGFb-1)
in the three groups of rats were significantly different from
each other (Table 2). OM had the highest levels of renal
TGFb-1: 715765 (pg/mg total kidney protein, ANOVA;
Po0.001 vs all others), followed by OF, 290772, whereas LM
had the lowest level in the set, 55713.
Inactivation of renal 3-hydroxyisobutyrate dehydrogenase
by 4-HNE
The mitochondrial enzyme 3-hydroxyisobutyrate dehydro-
genase (HIBADH) was studied because it is preferentially
expressed in kidney,25 and is susceptible to oxidative
modulation.26 The direct toxicity of 4-HNE on HIBADH
was examined on renal mitochondria isolated from normal
male Wistar rats, and then exposed in vitro to 50 mM 4-HNE
(Figure 6a). A second group of renal mitochondria was
included as untreated control and represented 100% enzyme
activity. The concurrent incubations were conducted for up
to 10 min, and quenched with 50 mM glutathione at time zero
(99.770.2% activity in sample 1), 2 min (73.170.4%
residual activity in sample 2), 5 min (52.770.3% residual
activity in sample 3), and 10 min (29.270.2% residual
activity in sample 4, n¼ 3, ANOVA, Po0.001 for all). The
rapid inhibition of renal HIBADH activity indicated high
susceptibility of this key renal mitochondrial enzyme to
inactivation by 4-HNE.
The activity of HIBADH in renal cortex homogenates
of obese and lean rats was then measured at termination
(Figure 6b). HIBADH specific activity levels were
53275 nmol/min/mg in LM, 35972 nmol/min/mg in OF,
and 10171 NADH nmol/min/mg in OMs. The groups are all
significantly different from each other (n¼ 3, ANOVA,
Po0.001).
Subsequently, HIBADH tissue levels from the same
kidneys were measured on Western blots with a specific
a b c
Figure 3 | Glomerular localization of LOX-1 by immunohisto-
chemistry. (a) The label for LOX-1 was very strong in glomeruli of OM
rats. In contrast, LOX-1 was barely detectable in (b) OF and (c) LM.
The fractional area expressing LOX-1 was more extensive in OM than
in OF and LM (Table 2).
Table 2 | Renal peroxidation and fibrosis indices at 41 weeks
of age
Parameter LM OM OF
% Glomerular LOX-1 6.072.4 49.474.7 9.873.1
% HNE 18.671.5 60.870.31a 14.673.7
% Glomerulosclerosis 1.270.4 66.6710.6 12.870.7
% Tubular atrophy 0.170.1 41.578.4a 9.171.7
% Interstitial fibrosis 5.871.2 91.174.1a 39.076.8b
Renal TGFb-1 55713 715765a 290772b
HNE, hydroxynonenal; LM, lean males; LOX-1, oxidized low-density lipoprotein
(LDL) receptor 1; OF, obese females; OM, obese males; TGFb-1, transforming growth
factor b-1.
TGFb-1 is expressed as pg/mg protein.
aSignificantly different than OF and LM, Po0.05.
bSignificantly different than LM, Po0.05.
a b c
Figure 4 | Glomerular 4-HNE. The accumulation of 4-HNE was
far more prominent in glomeruli of (a) OM rats than in (b) OF,
or (c) LM. (c) The glomerular fractional area of reacting 4-HNE
antibody was more extensive in glomeruli from OMs than in OF
and LM (Table 2).
a b c
Figure 5 | Kidney photomicrographs (original magnification,
 200). (a) LM, (b) OM, and (c) OF. The zones of fibrosis (blue) were
clearly differentiated from viable tissue (pink). In males, severe
glomerulosclerosis and interstitial fibrosis with tubular atrophy are
very apparent, whereas fibrosis and tubular decay was not observed
in LM, and barely detectable in OF.
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antibody to rat recombinant HIBADH, Figure 7. The tissue
levels were depressed in the same proportion, suggesting that
the loss of activity in OM was in part related to lower enzyme
numbers. It is not yet clear whether the decrease in this
enzyme was owing to specific changes in gene expression,
decrease in mitochondrial content, or degradation of enzyme
in diseased tissues.
Renal rat albumin in obese rats
The membrane blots used for the data shown in Figure 7
showed disproportionate densities of stained protein bands:
one band was particularly dense in OM, intermediate in OF,
and barely detectable in LM and normal Wistar rats. In
contrast, a lower molecular weight band was lighter in OM
and progressively more prominent in OF, LM, and Wistar rat
controls (Figure 8). These two bands were excised, digested
with trypsin, subjected toelectrospray ionization-mass spec-
trometry, and their amino-acid sequences were determined
by collision-induced dissociation. Their sequences were
identical to rat serum albumin (upper band) and the beta-
globin chain of hemoglobin (lower band) as indicated by the
database of the IMAGE Consortium (http://www.ncbi.
nlm.nih.gov/). These results imply that in OM there was
greater deposition of albumin in renal tissue. It is unlikely
that these results were caused by whole blood trapped in the
kidneys of OM, as their content of blood-borne beta-globin
changed in the opposite direction (Figure 8).
Renal adiposity and inflammation in younger rats
The study of 41-week-old rats revealed a male-specific
preponderance of renal lesions. However, multiple levels of
injury were uncovered, including mitochondrial enzyme
dysfunction, renal fibrosis, and compromised renal vascular
permeability barrier. Consequently, it was not possible to
elucidate potential pathogenic mechanisms of nephropathy
this late in the course. Hence, lean plus OM, and OF ZS rats
were studied from 6 to 16 weeks of age. There were three
issues investigated at this earlier age: differences in micro-
albuminuria, renal adiposity, and renal inflammation. At 16
weeks of age, renal injury was already more severe in OM
than OF, as indicated by their significantly larger kidneys that
leaked more albumin in the urine (Table 3). On the other
hand, renal adiposity was equally severe in OM and FM, as
indicated by renal triglyceride levels and by distribution of
renal fat deposits (Figure 9). Furthermore, renal levels of
AMPK-a-activated protein kinase (AMPK-a) and its phos-
phorylated (active) form were more depressed in OF kidneys
than OM kidneys (Figure 10), a finding consistent with
increased energy storage and lipogenesis in OF kidneys.27 On
the other hand, OM kidneys contained higher levels of
TBARS, consistent with greater renal oxidative stress occurr-
ing at this younger age. Moreover, marked differences were
also observed in the number of renal inflammatory cells of
OM, as specific cellular stains showed increased number
of interstitial macrophages and polymorphonuclear cells
(Table 3, Figure 11).
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Figure 6 | Inactivation of renal HIBADH by 4-HNE. (a) Renal
mitochondria isolated from normal Wistar rats were incubated in vitro
to 50 mM 4-HNE for 10 min, and quenched with 50 mM glutathione at
time zero, 2, 5, and 10 min. The data were normalized to enzyme
activity measured concurrently in mitochondria untreated with
4-HNE, which represented 100% activity. Each circle represents the
mean of three determinations, and the error bars are within the circle.
(b) Renal HIBADH in whole kidney homogenates in OM, OF, and LM.
The data are from three experiments combined, and the error bars
are within the columns.
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Figure 7 | Renal HIBADH protein levels by Western blot. Very low
levels of renal HIBADH were detected in OM, intermediate in OF,
whereas LM had the highest levels (top). The relative protein levels
were verified by densitometry (bottom).
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Figure 8 | Rat serum albumin in OM rat kidneys. The membranes
used for Western blots (see Figure 7) showed disproportionate
densities of stained protein bands: one band was particularly
dense in OM, intermediate in OF, and barely detectable in LM
and normal Wistar rats (upper arrow). A lower molecular weight
band was much lighter in OM and progressively more prominent
in OF, LM, and Wistar controls. These two bands were excised,
digested with trypsin, subjected to electrospray ionization-mass
spectrometry, and their amino-acid sequences were determined by
collision-induced dissociation. Their sequences were identical to rat
serum albumin (upper band) and the beta-globin chain of
hemoglobin (lower band) as indicated by the database of the
IMAGE Consortium.
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DISCUSSION
OM rats with dyslipidemia and type II diabetes sustained
oxidative renal damage when ingesting an atherogenic diet
from 6 to 41 weeks of age. The advanced renal injury was
linked to glomerular expression of LOX-1 and accumulation
of 4-HNE, a toxic end product of lipid peroxidation28 that
accumulates in the mitochondria.29 Furthermore, 4-HNE
inhibited renal HIBADH, a redox-sensitive mitochondria
enzyme that is rate limiting for valine catabolism, and critical
for gluconeogenic flow.25,26,30,31 Kidneys from OM had lower
levels of HIBADH, and also demonstrated severe infiltration
of serum albumin, consistent with either greater disruption
of the renal endothelial vascular interface or greater
nonspecific binding of albumin in OM. Conversely, OF were
much less affected, and LM were unaffected. Although renal
injury in younger OM (6–16 weeks of age) was more severe
than same-age OF and LM, renal lipid loads in obese animals
were comparable for both sexes. In marked contrast, greater
renal oxidative stress and more inflammatory cells were
observed in younger OM than in younger OF.
Dyslipidemia in ZS rats progressed with age, and it was
similar to prior reports from us,10 and others in rat models of
hyperlipidemia with diabetes.32,33 The extremely high
cholesterol and triglyceride levels in obese rats likely
contributed to the marked elevations of circulating hydro-
peroxide, as previously shown in rats33 and humans.34
However, OM appeared to sustain a more severe oxidation,
as indicated by higher levels of circulating and tissue free
aldehydes (TBARS).
The renal injury of OM was characterized by glomerular
sclerosis and interstitial fibrosis, with tubular dilatation and
atrophy, similar to changes induced by oxidized lipids10 or
cholesterol feeding.35 We propose that this nephropathy was
caused in part by renal lipid peroxidation, as indicated by
heavy formation of 4-HNE/protein adducts.36,37 Indeed,
4-HNE is toxic to mitochondrial enzymes,36–38 which was
verified herein with renal HIBADH, a redox-sensitive
enzyme.25,26 We suggest that hydroperoxides in very low-
density and low-density lipoproteins33 were internalized by
expressed glomerular endothelial LOX-123,24,39 in OM, or by
other multifunctional cell-surface receptors.40,41 Moreover,
lipid oxidants derived from either diet precursors42 or by
intrinsic glycoxidation stress43 most likely stimulated renal
LOX-1 expression in glomerular endothelium,44–46 whereas
excessive renal production of TGFb-1 (below) might also
have had a stimulatory role.47 We presume that oxidized
lipoproteins cleared by the kidney48 released reactive oxygen
species, including highly reactive 4-HNE,49 and damaged the
glomerular endothelium. Although unutilized lipid renal
loads could be a source of cell dysfunction in the metabolic
Table 3 | Renal unutilized fat, inflammatory cells, and
microalbuminuria at 16 weeks of age
Parameter LM OM OF
Body weight 39378 49277a 44676a,b
Kidney weight 1.3370.04 1.6870.07a 1.2370.04b
Kidney triglycerides 0.06470.009 0.12470.017a 0.13070.008a
Kidney TBARS 3673 63713a 2773
PT. macrophages 3.970.3 7.870.5a 4.570.3b
PT. PMN 0.3170.06 0.5870.08a 0.4370.06
Urine albumin/creatinine 0.04870.007 1.20370.118a 0.67570.155a,b
Abbreviations: LM, lean males; OF, obese females; OM, obese males.
Body and kidney weights are in grams. Kidney triglycerides are in mm/mg protein.
TBARS are in pM/100 mg renal protein. PT designates peritubular cells per  400
field. PMN represents polymorphonuclear cells. The cell counts are average number
per  400 field obtained in 25 separate fields in each rat. Urine albumin is expressed
as albumin/creatinine ratio (mg/mg).
aSignificantly different than lean males; Po0.05.
bSignificantly different than obese males; Po0.05.
a b c
Figure 9 | Renal lipid stain with Oil-red-O in 16-week-old rats. The
presence of renal lipid was barely detectable in (a) LM kidneys,
whereas prominent in (b) OM and (c) female kidneys.
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Figure 10 | Renal AMPK. (a) The renal AMPK a-subunit and (b)
phosphorylated-AMPK a-subunit were detected with specific
antibodies on Western blots. The relative levels of these two
proteins were measured by densitometry and found to be
depressed in OF when compared to LM and OM.
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Figure 11 | Kidney photomicrographs (original magnification,
 400). (a–c) Renal macrophages were identified by immunohisto-
chemistry (brown label, arrows) in LM, OM, and OF, respectively. (d–f)
( 1000) Renal polymorphonuclear cells were identified by immuno-
histochemistry (red label, arrows) in LM, OM, and OF, respectively.
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syndrome,50 this mechanism alone may not account for the
gender differences of metabolic-induced renal injury, as both
young OM and females exhibited comparable renal loads of
unutilized lipids. Moreover, renal levels of AMPK-a, the
prime stimulant for ATP generation via fatty acid oxidation
and glycolysis, were more depressed in OF than OM. On the
other hand, young OM with severe metabolic nephropathy
depicted greater numbers of macrophages, which may be key
participants in renal inflammatory responses, cell decay, and
fibrosis. Whatever the mechanism, the severity of renal injury
was linked to proportional levels of renal TGFb-1 levels in
obesity, as previously shown by us in another strain of obese
rats.10 Accordingly, we suggest that an inflammatory inter-
action between lipid peroxidation,10 LOX-1 expression,42 and
high renal TGFb-1 levels12 may account, in part, for nephro-
pathy in the metabolic syndrome. In further support of this
notion are reports that cells expressing LOX-1 internalize
lipid peroxides, which activate inflammatory signals,49 and
also serve as adhesion templates for inflammatory cells.51
Hypertension is an important risk factor for nephropathy
in diabetes,4 and it is relevant in obese rats with diabetes.52 In
OM, but not female rats, hypertension was linked to injury,
suggesting that damaging effects of hypertension were
affected by gender-specific factors, either blunted in OF rats
or aggravated in OM rats. It is also possible, albeit less likely,
that hypertension, acting independently, was not the cause of
renal failure in rats with the metabolic syndrome.
MATERIALS AND METHODS
Subjects
The pathogen-free rats used in these investigations were from
Genetic Models Inc. (GmiTM, Indianapolis, IN, USA). We studied F1
hybrid rats derived from two well-characterized parental strains: the
ZDF(fa/fa; Zucker et al.13 and Kamran et al.16) and the spontaneous
hypertensive heart failure rat (SHHF/Gmi-fa).19 There were two
groups of rat maintained in our animal facility from birth until
termination at 41 weeks of age (group 1) and 16 weeks of age (group
2). In group 1, there were 10 OM, 13 OF, and 10 LM. In group 2,
there were five LM, five OM, and five OF. The rats were fed ad lib,
and were housed in steel cages and acclimatized to 12-h cycles of
light and darkness (0700–1900 hours). The diet was PurinaTM no.
5008, which contained 27% protein, 17% animal fat, and 56%
carbohydrate. The diet lipid hydroperoxide content measured in our
laboratory was 11.1 mM/g of solid.
The body weights and blood metabolic profiles of the rats were
monitored throughout the experiment. Blood samples were
obtained by sequential tail vein drawings and at termination. All
kidneys were examined for hydronephrosis, and none were dilated.
Blood analysis
The blood levels of triglyceride, cholesterol, creatinine, and blood
urea nitrogen were measured on a Beckman CX4CE Clinical System
in blood drawn from the tail vein. Diet and plasma lipid
hydroperoxides were determined spectrophotometrically by Fe2þ
oxidation in the presence of xylenol orange.53 For each assay,
aliquots of diet extract or plasma were diluted 90ml with H2O, and
hydroperoxides were measured exactly as described.10,53 The results
were expressed as mmoles of lipid hydroperoxide. Plasma free
aldehydes were detected with the thiobarbituric acid reaction as
described.54 Standard curves were run with each assay using
malonaldehyde bis(dimethyacetal) as the known standard.
Renal histology and immunohistochemistry
Renal histology, immunohistochemistry, and morphometry were
conducted on paraffin-embedded renal sections.55 Each entire
kidney section was analyzed; all glomeruli and tubules were
included in the calculations, and any degree of glomerular sclerosis,
ranging from focal to global lesions, was considered positive.
Glomerular sclerosis and tubular atrophy data were expressed as
fractions of the total number of glomeruli and tubules. Interstitial
fibrosis was expressed as the percent of the fibrosis area in trichrome
dye-stained sections.
Immunohistochemistry was carried out on 5 mm renal sections
mounted on lysine-coated glass.56 The VectastainTM immunostaining
protocol was employed as described by the manufacturer (Vector
Laboratory, Burlingame, CA, USA). To test for lipid peroxidation,
we used a specific polyclonal antibody to 4-HNE-keyhole limpet
hemocyanin raised in rabbits, which were immunized with dialyzed
keyhole limpet hemocyanin previously reacted with 4-HNE (the
anti-4-HNE antibody was a generous gift of Dr AN Siakotos,
Indiana University, Indianapolis, Indiana, USA). The antibody is
specific, as indicated by preadsorption of antibody to a 4-HNE-
keyhole limpet hemocyanin, and identifies 4-HNE adducts on
Western blots57 and by immunohistochemistry of affected rat
kidneys.10 The anti-4-HNE antiserum was used at a dilution of
1:1000. The anti-rat LOX-1 antibody was raised in rabbits against
recombinant LOX-1.39,24 The specificity of the antibody was
confirmed by preadsorption of antibody with excess purified LOX-1
antigen in Western blotting39 and tissue immunohistochemistry
corresponds to LOX-1 in situ hybridization signal.24 Anti-LOX-1
antibody (1:1000) and pre-immune rabbit serum (negative control)
were applied to renal sections and then they were exposed to
biotinylated secondary antibody, reacted with horse peroxidase
substrate (DAB; Vector Laboratory), and stained with hematoxylin–
eosin. The areas labeled with anti-LOX-1 and 4-HNE antibodies
were expressed as fractions of glomerular areas.
Renal polymorphonuclear leukocytes were labeled with naphta-
nol-AS-D-chloracetate esterase (Leder stain kit was from Poly
Scientific, R&D, Bay Shore, NY, USA). Macrophages were labeled
with anti-rat macrophage mouse monoclonal MAB1435 (Chemicon,
Temecula CA, USA; Damoiseaux et al.58) followed by a rabbit anti-
mouse second antibody (LSAB2 kit from Dako, Carpinteria, CA,
USA). The labeled cells were visualized at  400 original
magnification in 25 separate kidney fields per each animal, and
expressed as cell number per  400 field.
The renal morphometric analysis was conducted with the
program Sigmascan and Sigmascan Pro, v. 4.0 (from SPSS Inc.,
Chicago, IL, USA).
Enzyme-linked immunosorbent assay
Renal levels of (TGFb-1) levels were measured by sandwich enzyme-
linked immunosorbent assay as described.10 The two anti-TGFb-1
antibodies and enzyme-linked immunosorbent assay protocol were
from R&D Systems (Minneapolis, MN, USA).
Isolation of renal mitochondria
Mitochondria were isolated from renal cortices of four normal
Wistar rats (Charles River, Indianapolis, IN, USA). The kidneys were
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homogenized in ice-cold buffer (mannitol, 225 mM; sucrose, 75 mM;
3-[N-morpholino]propane sulfonic acid, 10 mM; ethyleneglycol
tetraacetate, 1.0 mM; and 5% bovine serum albumin, pH 7.5). The
mitochondria were isolated by differential centrifugation.
Activity of renal HIBADH and Western blots
The enzymatic activity of HIBADH was measured in total renal
homogenates as described previously, using S-HIBADH as
substrate, and reported as nmoles nicotinamide adenini dinucleo-
tide (reduced form)/min/mg protein.30 The proteins were separated
by a 12% acrylamide sodium dodecyl sulfate-polyacrylamide
gel electrophoresis, electrophoretically transferred to a BIO-RAD
Immuno-Blot polyvinylidene difluoride membrane (Bio Rad,
Hercules, CA, USA) at 15 mA, and labeled with HIBADH-specific
primary rabbit polyclonal antibody (1:500) raised in rabbits against
recombinant rat HIBADH30,31 followed by peroxidase-linked
secondary anti-rabbit immunoglobulin G goat antibody (Pierce,
Rockford, IL, USA). The sensitivity for HIBADH detection on
Western blots was in the nanogram range.31 The levels of AMPK-
a-activated kinase (AMPK-a) and phosphorylated-AMPK were
measured on Western blots. The AMPK-a antibody was an affinity-
purified specific rabbit polyclonal antibody to synthetic AMPK-a
peptide. The phospho-AMPK-a (Thr172) (40H9) is a rabbit
monoclonal antibody that detects endogenous AMPK-a only when
phosphorylated at Thr 172. The antibody was raised against
synthetic phosphopeptide (1:1000 dilution; source of product and
information is Cell Signaling, Beverley, MA, USA). Relative protein
intensity levels were measured on antibody-stained membranes and
Comassie-stained SDS-PAGE gels using VitaScan software (ESA
Inc., Chelmsford, MA, USA).
Identification of renal proteins by electrospray
ionization-mass spectrometry
Two specific renal protein bands were isolated from Coomassie-
stained SDS-PAGE gels. The proteins were digested with modified
trypsin (Roche Biochemicals, Indianapolis, IN, USA) using a
standardized in-gel digestion protocol and the resulting peptides
were analyzed by LC-MS and LC-MS/MS in the Biochemistry
Biotechnology Facility at Indiana University School of Medicine.
Peptides were applied to a 500mm inner diameter capillary column
packed with Vydac C18 resin and eluted with a standard gradient of
acetonitrile in the presence of 0.01% trifluoroacetic acid, 0.1% acetic
acid, and 0.2% isopropanol. Peptides were eluted directly into the
ionization source of a Finnigan Launch Crew Quarters mass
spectrometer. Mass spectra were recorded with an m/z range of
200–2000, and base-peak ions were subjected to collision-induced
dissociation with a collision energy of 35%. Spectral data were
subjected to database searches using SeQuest software (Finnigan,
Corp., San Jose, CA, USA).
Materials
Bovine serum albumin was from ICN Biomedicals (Irvine, CA,
USA). Teleost gelatin, leupeptin, pepstatin, aprotinin, and all other
reagent grade chemicals were from Sigma Chemical Co. (St Louis,
MO, USA).
Statistical analysis
The data are expressed as mean7s.e.m. Statistical differences
between groups were calculated by ANOVA test (Statistica, Stat
Soft version 4.5, Tulsa, OK, USA).
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